Clinical Trial Update: Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposomal mitoxantrone in combination with cytarabine and venetoclax for relapsed/refractory acute myeloid leukemia; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Liposomal mitoxantrone (mitoxantrone)
• Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy | Phase 2 | Status: RECRUITING